Achieve life sciences, inc. (ACHV)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
COLLABORATION REVENUE [note 3]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,122

2,940

-

6,737

4,025

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

COLLABORATION REVENUE (note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,374

-

4,803

4,929

11,731

8,604

9,862

6,340

5,076

9,780

6,570

2,429

1,316

1,236

1,174

1,887

1,199

4,881

1,701

EXPENSES
Research and development

1,541

1,763

1,824

2,032

4,055

2,081

1,541

1,045

1,201

2,153

825

62

61

-12,800

3,782

4,662

4,642

-14,741

8,303

6,545

3,673

9,852

9,586

9,883

16,903

13,195

18,004

13,263

10,855

15,645

12,895

6,326

5,082

7,477

3,814

5,409

4,853

6,723

3,079

General and administrative

1,816

1,446

1,893

1,630

1,885

1,628

1,753

1,751

1,813

1,628

1,550

93

260

-5,210

1,864

2,475

2,299

-5,076

3,125

3,067

2,698

2,733

2,459

2,676

2,757

2,446

2,473

2,473

2,500

2,042

1,965

2,047

1,737

1,731

1,457

1,471

1,571

1,067

1,475

Restructuring costs (recovery) [note 8]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-31

-8

431

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Recovery of lease termination loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation settlement [note 7]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,375

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring gain [note 7]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,038

-

Total operating expenses

3,357

3,209

3,717

3,662

5,940

3,709

3,294

2,796

3,014

3,781

2,375

155

321

-18,527

4,365

8,504

7,372

-19,817

11,428

9,612

-

-

-

12,559

19,660

-

20,477

15,736

13,355

16,030

14,860

8,373

6,819

33,510

-5,271

-6,880

6,424

11,828

4,554

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,371

-

12,045

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

OTHER INCOME (EXPENSE)
LOSS FROM OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,097

4,993

-5,225

-6,947

-2,853

Interest income

42

27

40

41

62

83

61

17

10

-

9

-

-

-

53

61

48

28

24

13

54

16

3

4

12

26

33

39

52

65

86

91

50

52

49

63

56

25

14

Other expenses

-

-

-

3

-

-

-

9

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bargain purchase gain [note 2]

-

-

-

-

-

-

-

-

-

-

1,272

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent value rights recovery [note 2]

-

-

-

-

-

-

-

-

-

-

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

531

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on warrants

-

-

-

-

-

-

-

-

-

-

-111

-

-

-

-621

533

-667

-1,730

-131

429

-465

-973

-2,874

-615

721

-334

-539

-901

-1,434

-1,937

-2,308

-1,644

1,430

1,633

-8,580

1,687

-2,128

-

-

Loss on disposition of intangible asset [note 5]

-

-

-

-

-

-

-

-

-

-

-8,610

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expenses

-5

-

4

-

-26

-

-7

-

-

-9

-7

-11

-8

0

1

-35

10

9

-14

-7

-39

-6

-11

-4

2

-1

-11

36

96

145

-24

-6

23

-15

-62

87

-4

28

-7

Total other income (expense)

37

15

44

38

36

72

54

8

-8

42

-7,025

-11

-8

-917

675

-507

725

270

141

-423

480

983

2,335

615

-707

359

561

976

1,582

2,147

2,370

1,729

-1,357

15,574

-8,567

-1,573

2,180

53

7

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-3,739

-9,400

-166

-329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,470

6,530

-3,045

-6,894

-2,846

Recovery of deferred income taxes [note 5]

-

-

-

-

-

-

-

-

-

1

-2,928

0

-124

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax recovery [note 10]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-3,000

Net loss

-3,320

-3,194

-3,673

-3,624

-5,904

-3,637

-3,240

-2,788

-3,022

-3,740

-6,472

-166

-205

13,052

-3,690

-6,889

-3,707

9,732

-4,550

-6,010

-4,517

-5,682

-4,907

-7,015

-8,636

-6,678

-10,054

-8,420

-6,697

-4,103

-5,920

-4,215

-6,860

-13,688

-4,470

6,530

-3,045

-6,894

154

Net unrealized gain on foreign exchange

-

-

-

-

-

-

-

-

-

-

-

-1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net unrealized gain on securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7

4

14

-10

5

2

13

-15

-4

-1

-1

3

24

-15

-6

-

38

-

-

-

-

-

-

-

-

Total other comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

-1

-

-7

-7

4

14

-6

5

2

13

-15

-4

-1

-1

3

24

-15

-6

-

-

-

-

-

-74

-54

-

-

-

Unrealized gain on cash equivalents and marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70

-

-

Net unrealized loss on securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19

-5

-

-74

-54

-48

-

-

Total other comprehensive (loss) income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

-

-

Comprehensive loss

-3,320

-3,194

-3,673

-3,624

-5,904

-3,637

-3,240

-2,788

-3,022

-3,739

-6,472

-167

-205

13,045

-3,697

-6,885

-3,693

9,726

-4,545

-6,008

-4,504

-5,697

-4,911

-7,016

-8,637

-6,675

-10,030

-8,435

-6,703

-4,116

-5,882

-4,234

-6,865

-13,807

-4,396

6,584

-3,023

-

-

Basic and diluted net loss per common share

-0.11

-0.16

-0.45

-0.50

-0.88

1.35

-0.71

-1.82

-2.43

75.21

-8.96

-78.66

-9.66

-580.78

-0.12

-0.23

-0.12

-38.58

-0.16

-0.26

-0.20

-0.16

-0.23

-0.47

-0.59

-0.46

-0.68

-0.57

-0.46

-0.20

-0.40

-0.29

-0.67

-

-

0.67

0.31

-

-0.02

Weighted average shares used in computation of basic and diluted net loss per common share

30,936

10,974

8,100

7,189

6,721

6,734

4,533

1,529

1,243

1,171

722

2

21

-89,766

30,013

29,932

29,827

-51,960

28,538

23,484

22,656

21,606

21,079

14,987

14,721

14,708

14,690

14,673

14,660

-

14,619

-

-

-

-

-

-

-

-

Weighted average number of common shares [note 5]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,554

10,235

-

-

9,718

9,713

-

-

Basic loss (income) per common share [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.46

-

-

1.07

-

Diluted loss (income) per common share [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.45

-

-

1.07

-

Weighted average number of basic common shares [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,736

-

-

6,453

6,400

Weighted average number of diluted common shares [note 5(c)]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,043

-

-

6,453

6,529